Beata Stella‐Hołowiecka

Status of minimal residual disease after induction predicts outcome in both standard and high‐risk Ph‐negative adult acute lymphoblastic leukaemia. The Polish Adult Leukemia Group ALL 4‐2002 MRD Study

Jerzy Hołowiecki, Małgorzata Krawczyk‐Kuliś, Sebastian Giebel et al. · British Journal of Haematology · 2008 · 142 citations · Full text

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Sebastian Grosicki, Tadeusz Robak, Sławomira Kyrcz‐Krzemień et al. · Leukemia · 2004 · 125 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +8

Comparison of Cladribine Plus Cyclophosphamide With Fludarabine Plus Cyclophosphamide As First-Line Therapy for Chronic Lymphocytic Leukemia: A Phase III Randomized Study by the Polish Adult Leukemia Group (PALG-CLL3 Study)

Tadeusz Robak, Krzysztof Jamroziak, Joanna Góra‐Tybor et al. · Journal of Clinical Oncology · 2010 · 99 citations · Full text

Hematological Malignancy, Oncology, Mixed-phenotype Acute Leukemia +15

A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in <i>FIP1L1‐PDGFRA‐</i>expressing patients

Grzegorz Helbig, Beata Stella‐Hołowiecka, Mirosław Majewski et al. · British Journal of Haematology · 2008 · 81 citations · Full text

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial

Tadeusz Robak, Krzysztof Jamroziak, Joanna Góra‐Tybor et al. · Blood · 2007 · 75 citations · Full text